Registry tracks donor lungs preserved with LungGuard device before transplant
Collects outcomes of lung transplant patients receiving donor lungs kept in LungGuard.
Plain-language title generated from the registry record
Registry title: Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
Key facts
- Where
- Leuven, BelgiumSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry follows people who receive a donor lung transplant, including children. It compares lungs carried in the LungGuard system with lungs carried by other methods.
- Age
- Adults and children (no age limits stated).
- Sex
- Men and women.
- Disease stage
- People registered as candidates for a first lung transplant.
- Earlier treatment
- Cannot have had a major organ transplant before (heart, lungs, liver, kidney, pancreas).
Main reasons for not taking part
- Donor lungs that do not meet the hospital's requirements for transplant
- People who are incarcerated (prisoners)
- A previous major organ transplant (heart, lungs, liver, kidney, pancreas)
- Receiving more than one organ transplant
This trial only enrols participants who have had an organ transplant. The registry sentence this rests on: Registered male or female primary lung transplant candidates including pediatric candidates
Read by machine on 12 November 2026.
Where in Belgium
- University Hospitals LeuvenLeuven, BelgiumNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Paragonix Technologies
- Trial code
- NCT04930289
- Record updated
- 18 September 2026
- Original description
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported within the LUNGguard system, as well as retrospective standard of care patientsRead full original descriptionShow less
Global Utilization and Registry Database for Improved Preservation of Donor Lungs
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported within the LUNGguard system, as well as retrospective standard of care patients
Inclusion: Donor and donor lungs matched to the prospective recipient based upon institutional medical practice; Registered male or female primary lung transplant candidates including pediatric candidates.
Exclusion: Donor and donor lungs that do not meet institutional clinical requirements for transplantation; Patients who have had a previous major organ transplant (heart, lungs, liver, kidney, pancreas); Patients who are receiving multiple organ transplants; Patients who are incarcerated persons (prisoners).